Evaluation of anti-pneumococcal capsular antibodies as adjunctive therapy in experimental pneumococcal meningitis

被引:3
作者
Brandt, Christian T.
Frimodt-Moller, Niels
Lundgren, Jens D.
Pedersen, Michael
Skovsted, Ian C.
Rowland, Ian J.
Ostergaard, Christian
机构
[1] Statens Serum Inst, Natl Ctr Antimicrobials & Infect Control, DK-2300 Copenhagen S, Denmark
[2] Univ Copenhagen, Hvidovre Hosp, CHIP, DK-2650 Hvidovre, Denmark
[3] Univ Copenhagen Hosp, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark
[4] Univ Copenhagen, Hvidovre Hosp, Danish Res Ctr Magnet Resonance, DK-2650 Hvidovre, Denmark
[5] Univ Copenhagen, Herlev Hosp, Dept Clin Microbiol, DK-2730 Herlev, Denmark
关键词
experimental meningitis; pneumococcal anti-serum; sepsis; outcome;
D O I
10.1093/jac/dkl401
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: Bacteraemia concomitant with meningitis has been shown to greatly affect outcome. Consequently, the efficacy of serotype-specific anti-pneumococcal antiserum (APAS) was investigated in a rat model of pneumococcal meningitis. Methods: Rats were infected with Streptococcus pneumoniae serotype 3. All rats received ceftriaxone starting 26 h post-infection. APAS was administered either at the time of infection or 26 h post-infection and effects were compared with rats treated with antibiotics only. Results and conclusion: A significant clinical benefit was found when APAS was given at the time of infection whereas no effect was found when administered 26 h after infection. This work indicates that the clinical value of using APAS in pneumococcal meningitis may be limited.
引用
收藏
页码:1291 / 1294
页数:4
相关论文
共 10 条
[1]  
AVERY OT, 1917, 7 ROCK I MED RES
[2]   Attenuation of the bacterial load in blood by pretreatment with granulocyte-colony-stimulating factor protects rats from fatal outcome and brain damage during Streptococcus pneumoniae meningitis [J].
Brandt, CT ;
Lundgren, JD ;
Lund, SP ;
Frimodt-Moller, N ;
Christensen, T ;
Benfield, T ;
Espersen, F ;
Hougaard, DM ;
Ostergaard, C .
INFECTION AND IMMUNITY, 2004, 72 (08) :4647-4653
[3]   Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitis [J].
Brandt, CT ;
Lundgren, JD ;
Frimodt-Moller, N ;
Christensen, T ;
Benfield, T ;
Espersen, F ;
Hougaard, DM ;
Ostergaard, C .
JOURNAL OF NEUROIMMUNOLOGY, 2005, 166 (1-2) :126-131
[4]   Pneumococcal meningitis in adults - Spectrum of complications and prognostic factors in a series of 87 cases [J].
Kastenbauer, S ;
Pfister, HW .
BRAIN, 2003, 126 :1015-1025
[5]   Pneumococcus and streptococcus meningitis chemotherapy and serum therapy, with especial reference to newer methods [J].
Kolmer, JA .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1929, 92 :874-877
[6]   Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection -: art. no. 93 [J].
Ostergaard, C ;
Konradsen, HB ;
Samuelsson, S .
BMC INFECTIOUS DISEASES, 2005, 5 (1)
[7]   Influence of the blood bacterial load on the meningeal inflammatory response in Streptococcus pneumoniae meningitis [J].
Ostergaard, Christian ;
O'Reilly, Terence ;
Brandt, Christian ;
Frimodt-Moller, Niels ;
Lundgren, Jens D. .
BMC INFECTIOUS DISEASES, 2006, 6 (1)
[8]   Dexamethasone and pneumacoccal meningitis [J].
van de Beek, D ;
de Gans, J .
ANNALS OF INTERNAL MEDICINE, 2004, 141 (04) :327-327
[9]   Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series [J].
Weisfelt, M ;
van de Beek, D ;
Spanjaard, L ;
Reitsma, JB ;
de Gans, J .
LANCET NEUROLOGY, 2006, 5 (02) :123-129
[10]   Combined effect of specific antibodies (as serotherapy or preimmunization) and amoxicillin doses in treatment of Streptococcus pneumoniae sepsis in a mouse model [J].
Yuste, J ;
Fenoll, A ;
Casal, J ;
Giménez, MJ ;
Aguilar, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (12) :4043-4044